Home injection treats Alzheimer's

 Home injection treats Alzheimer's

An experimental version of an Alzheimer's drug, which can be given at home, has been shown to be effective in removing 14% of amyloid protein, which accumulates on brain cells.

The home version of the injection outperformed Leqembi, which was approved and is given in a hospital every two weeks.

Alzheimer's treatment

Eisai Co., which produces both versions of the drug, presented the results of the trial yesterday, and according to Medical Express, it was found that the rates of major side effects such as brain swelling and bleeding were similar between the two injections.

The trial lasted 6 months, and compared 72 patients who received injections of the new home formula and 322 patients who received injections of Compi. The study did not compare the cognitive effects of the two versions.

The drug Kampi was approved last July in the United States, and is given intravenously in the hospital every two weeks, after it was proven to slow the course of Alzheimer's.

Two doses every week

Eisai's version of Kembe's injection will likely be given at home in two doses each week.

Eisai is seeking to approve the new home injection, to compete with the drug "Donanemab" from Lilly, which is taken only once a month and removes amyloid quickly, and some patients may be able to stop treatment after about a year.